Kremyanskaya Highlights the Benefits of BET Inhibitors in Myelofibrosis
Season 9, Episode 7, Jul 03, 2023, 06:00 PM
Dr Kremyanskaya discusses the results from cohort 1 of the MANIFEST trial in treatment-naïve myelofibrosis, differentiating features of pelabresib and recently approved JAK inhibitors, and next steps for the investigation of BET inhibitors in this population.